← the 2026-10-28 wrap
SPY · 2026-10-28 · weekly change

XYL

Xylem

covered 3 times →
-17.04%
Neutral
Catalyst

Xylem cut 2026 adjusted EPS guidance to $5.40-5.45 and organic growth to roughly flat, so shares fell 14.21% on results day.

Xylem designs, manufactures and services engineered water products for utility, industrial, and residential and commercial building settings. It reports through four segments, including Measurement and Control Solutions and Water Solutions and Services.

Price history

PriceS&P 500 (indexed)

Key facts

Close, 2026-10-28
$88.23
5-session move
-17.04%
from $106.35
Session range
$87.40 – $91.40
open $91.00
Volume
11.4m
4.5× 50-day avg
52-week range
$87.40close $88.23, 1% of the range$152.14
50-day avg
$105.91
200-day avg
$117.14
Market cap
$20.23bn
Forward P/E
14.4×
Dividend yield
1.85%
Year to date
-34.93%
Same period · Industrial Machinery & Supplies & Components
  • S&P 500 -0.17%
  • PH -4.83%
  • ITW -0.26%
  • OTIS +0.72%
  • IR -4.57%
  • GWW -0.82%
  • HUBB -5.45%

Market data from Yahoo Finance at the 2026-10-28 close, computed by the site, not the AI.

Analyst Report: XYL

1. EXECUTIVE SUMMARY

Xylem fell 17.04% over the five sessions to the close on October 28, from $106.35 to $88.23, and nearly all of the loss came on two days after the company reported third-quarter results on October 27. The stock dropped 14.21% on results day and a further 4.99% on October 28, when volume ran at 4.55 times the 50-session average. Per Investing.com, the quarter itself was close to expectations (adjusted EPS of $1.44 against a $1.45 estimate), and the damage came from a full-year guidance cut: organic revenue growth now roughly flat from 2-3%, and adjusted EPS of $5.40-5.45 from $5.55-5.70. Management attributed the shortfall to revenue conversion, citing project timing and weak water meter demand. The S&P 500 moved -0.17% over the same period, and the peer group was far milder, so the sell-off is specific to Xylem. Seven brokers cut or set targets on October 28, and the stock closed at its 52-week low area, with a session low of $87.40 that is the 52-week low.

2. THE CATALYST

Xylem reported Q3 2026 results before the open on Tuesday October 27 (Simply Wall St; Yahoo Finance/Zacks, both October 27). The shares closed at $92.86 that day, down 14.21%, on volume of 10,227,600. StockStory via Yahoo Finance reported the stock down about 9.7% in the morning session, so the decline deepened through the day.

Investing.com (October 28) gives the figures:

ItemPriorNew / Actual
2026 organic revenue growth2-3%roughly flat
2026 adjusted EPS$5.55-5.70$5.40-5.45
Adjusted EBITDA margin expansion90-130 bpsabout 100 bps
Q3 adjusted EPS$1.45 (estimate)$1.44
Q3 revenuen/a$2.3bn

The weakness came from the Measurement & Control Solutions and Water Solutions & Services segments, through delayed project timing and softer water meter demand (Investing.com). Part of the EPS cut came from unabsorbed interest expense on financing for the pending Cornell Pumps and Roper Pumps acquisitions. Management described a revenue conversion issue, said data center momentum was strong, and announced portfolio actions to move toward higher-growth, higher-margin end markets.

Sources conflict on revenue: Yahoo Finance headlines describe a miss, while Investing.com says $2.3bn slightly exceeded forecasts. The company release could not be opened, so this report does not rely on either characterisation.

On October 28 the stock fell a further 4.99% to $88.23 as analysts cut targets. Investing.com found no new company disclosure that day.

3. COMPANY PROFILE

Xylem designs, manufactures and services engineered products for utility, industrial, and residential and commercial building settings. It reports through four segments: Water Infrastructure, Applied Water, Measurement and Control Solutions, and Water Solutions and Services. Its brands include Flygt, Wedeco, Neptune Benson and Leopold. It sits in Industrials (specialty industrial machinery) with a market cap of $20.23bn.

Q2 2026 revenue was $2.34bn, up about 1.5% year on year, with adjusted EPS of $1.46 against a $1.34 consensus (ad-hoc-news). Stifel wrote on October 19 that Xylem had delivered on its 2026 commitments, while low organic growth, utility capex questions, electric meter headwinds and rotation into cyclical stocks had compressed the multiple. Xylem also completed a $1.5bn senior unsecured notes offering to fund the pump acquisitions (Investing.com, October 19).

4. DEEP DIVE ANALYSIS

Do fundamentals justify the move? The quarter landed within a cent of consensus EPS, so the sell-off follows the guidance. The EPS midpoint fell from $5.625 to $5.425, a cut of about 3.6%, against a two-day share price fall of 18.7% from the October 26 close of $108.24. The market has marked down the multiple as well as the earnings, which is consistent with the pre-results concern about low organic growth. Forward P/E is now 14.4. Flat organic growth with data centre strength and unresolved metering weakness gives investors little visibility, and that is inference on my part.

Peers. Over the same period, Parker-Hannifin fell 4.83%, Ingersoll Rand 4.57% and Hubbell 5.45%, while Illinois Tool Works moved -0.26%, W.W. Grainger -0.82% and Otis rose 0.72%. Investing.com reported the S&P Industrial Select Sector Index up about 0.6% on results day. The decline is stock-specific.

Analyst reaction (all October 28).

BrokerActionTarget
StifelBuy maintained$114 from $141
Goldman SachsBuy maintained$138 from $160
JPMorganDowngrade (neutral per MarketBeat; Investing.com reports Underweight, unresolved)$90 from $118
RBC CapitalOutperform maintained$125 from $135
OppenheimerOutperform maintained$135 from $150
BNP Paribas ExaneTarget cut$135 from $145
MizuhoTarget set$99

Every target other than JPMorgan's $90 and Mizuho's $99 sits well above the $88.23 close. JPMorgan's target is only modestly above it.

Comparable episodes. In April 2025 a cautious full-year forecast led to a roughly 15% monthly decline, and Stifel called it an opportunity (Investing.com, April 16, 2025). Several brokers had already trimmed targets earlier in October 2026: Barclays to $139, RBC to $135 and Stifel to $141.

Bull case. Management calls the problem conversion, not demand. Data centre demand is strong, portfolio reshaping targets better margins, and most brokers kept Buy-equivalent ratings with targets well above the price. The forward multiple of 14.4 is low against the stock's recent range.

Bear case. Guidance for flat organic growth follows a year-to-date decline of 34.93%. Project timing and metering weakness are not resolved, acquisition financing costs weigh on 2026 EPS, and a downgrade from JPMorgan adds to the pressure. A law firm published a shareholder-claims solicitation on October 28 (Morningstar), which carries no finding of wrongdoing.

5. TECHNICAL SNAPSHOT

The $88.23 close is the lowest in the daily table and sits just above the 52-week low of $87.40, set in the same session, so there is no nearer support level to name from recent closes. The price is below the 50-day average of $105.91 and the 200-day average of $117.14, and 42% below the 52-week high of $152.14 set on October 30, 2025. Volume of 11,407,100 on October 28 followed 10,227,600 the day before, each roughly four times the 50-session average of 2,505,912, so selling stayed heavy for a second day. The nearest resistance is the $92.86 close of October 27.

6. RISK FACTORS

  • Further guidance pressure if project conversion and metering weakness persist.
  • Execution and financing costs from the Cornell Pumps and Roper Pumps acquisitions. Closing timing was not confirmed in the sources.
  • Further estimate cuts, as analysts digest the new outlook.
  • Legal overhang from the shareholder-claims solicitation.
  • Unverified items: a GuruFocus headline on dividend sustainability could not be opened. The yield is 1.85%.
  • Upcoming catalysts: no dated events were sourced, and the next earnings date was not confirmed.

7. ACTIONABLE OUTLOOK

Short term (1-2 weeks). After two sessions of heavy volume and a close at the 52-week low area, the stock is pinned between the $87.40 low and $92.86 resistance. Further target changes and any company commentary on conversion will drive direction. No dated catalyst is sourced.

Medium term (1-3 months). Evidence of project timing recovering and metering stabilising would support the brokers' higher targets. Further delays would push the stock toward JPMorgan's $90 target and below. The next quarterly report, whose date is unconfirmed, is the main test.

Long term. Management's data centre commentary and portfolio actions remain the core of the thesis, and the brief gives no evidence that the water franchise itself has deteriorated. The guidance cut shows slower growth than previously expected, and the multiple has compressed to reflect that. This is analysis only and not personal financial advice.

researched and written by an AI agent · not financial advice